American Diabetes Association reverses expulsion of scientists over policy critique

The American Diabetes Association (ADA) has issued a formal apology after facing widespread criticism for ejecting five leading diabetes researchers from its annual conference. The incident unfolded when the scientists were distributing copies of an editorial published in the ADA’s own journal, Diabetes Care, which criticized the Trump administration’s impact on biomedical research.

Forced removal sparks backlash

The controversy began when the researchers—including Steven Kahn, editor-in-chief of Diabetes Care and a professor at the University of Washington—were asked to leave the conference for distributing the editorial outside the opening session. The editorial, published in April, condemned the Trump administration’s policies for undermining scientific integrity and funding cuts.

The scientists involved were Desmond Schatz, former ADA president and a professor at the University of Florida, along with four other prominent researchers. Their removal drew immediate condemnation from the scientific community, with many questioning the ADA’s commitment to academic freedom and open discourse.

The opening speech at the conference was originally assigned to Jay Bhattacharya, who served as director of the National Institutes of Health (NIH) under Trump. However, Bhattacharya canceled his appearance last minute, and the session was instead led by Rick Woychik, a senior NIH official.

ADA leadership reverses course

On Wednesday, ADA President Alice Bast posted a video apology addressing the incident. She acknowledged that the organization’s decision to remove the researchers was a mistake and expressed regret for the harm caused to the scientific community. Bast emphasized the ADA’s commitment to fostering constructive dialogue, even on controversial topics.

The backlash against the ADA’s actions highlights growing tensions between scientific institutions and political appointees. Many researchers argued that the expulsion set a dangerous precedent for suppressing dissent within professional organizations. The incident also reignited debates about the role of scientific journals in political discourse.

Broader implications for scientific integrity

The editorial in Diabetes Care was particularly notable for its direct criticism of the Trump administration’s approach to biomedical research. It cited funding reductions, political interference in grant reviews, and the suppression of scientific findings as key concerns. The journal’s decision to publish the piece—and the subsequent expulsion of its authors—has drawn attention to the challenges faced by researchers advocating for evidence-based policy.

The ADA’s reversal signals a shift in tone, but the episode underscores the need for clearer guidelines on political discourse within professional organizations. As scientific research becomes increasingly politicized, institutions must balance advocacy with neutrality to maintain credibility.

Moving forward, the ADA’s handling of this incident will likely be scrutinized as a test case for how professional bodies navigate contentious political environments while upholding scientific principles.